ENCYCLOPEDIA OF BEHAVIORAL MEDICINE, 3 VOLS. + ONLINE ACCESS
Gellman, M. - Turner, R.
Gastos de envío GRATIS en España y Portugal
Behavioral medicine is an interdisciplinary field concerned with the development and integration of sociocultural, psychosocial, behavioral and biomedical knowledge and techniques relevant to the understanding of health and illness and the application of this knowledge and these techniques to disease prevention, health promotion, etiology, diagnosis, treatment and rehabilitation.The original definition of the field of behavioral medicine was developed at the Yale Conference on Behavioral Medicine and later published by Gary Schwartz and Stephen Weiss . Since that time there have been various refinements to the definition as stated in the preceding definition. The overarching content structure will be based on the three fundamental domains within behavioral medicine, which yield three sections: Section I: Basic Research Section II: Clinical Investigation Section III: Public Health The domain of basic research addresses the key questions of mechanisms of action, both in terms of how behavior can have a deleterious effect on health, and how a change in behavior can be beneficial, either preventatively or therapeutically. The domain of clinical investigation then translates this knowledge into clinical interventions on a patient-by-patient basis. The third domain takes the broad view of how behavioral medicine can impact public health, and the system-wide/public education and advocacy/political activities that are needed to facilitate maximum benefits at the global level. It can immediately be seen from these brief descriptions of these domains that behavioral medicine is indeed a multidisciplinary and interdisciplinary field. Researching mechanisms of action requires a detailed knowledge of human biology, starting from the molecular genetic level and progressing to fully interacting body systems. A thorough understanding of environmental interactions with biological functioning is also necessary.The domain of basic research and clinical investigation are linked by the increasingly important concept of Translational Medicine, i.e., how to translate our mechanistic knowledge and understanding into successful clinical interventions most effectively and efficiently. The final challenge is to address these interventions at the public health level. It can therefore be seen that a very wide range of basic scientists, clinicians (physicians, nurses, and other allied health professionals), epidemiologists, and public policy experts contribute to the field of behavioral medicine.
Content Level » Professional/practitioner
Keywords » Addictive disorders - Adolescent health - Anxiety - Behavioral cardiology - Behavioral genetics - Complementary and alternative medicine - Disability - Exercise - HIV/AIDS - Health promotion - Sexual and reproductive health - Substance abuse - aging - behavior health interface - behavior modification - behavioral change - behavioral medicine - behavioral oncology - behavioral orthopedics - behavioral science - cancer - chronic disease - disease prevention - eating disorders - health behavior change - health psychology - nutrition - obesity - psychoneuroimmunology - stress and coping
Related subjects » Health Psychology & Behavioral Medicine - Medicine - Public Health - Social Sciences
Marc Gellman, PhD, is Research Associate Professor of Psychology, University of Miami, FL, where he is also Associate Director of the Behavioral Medicine Research Center, Associate Director of the Health Psychology Training Program, and Associate Director of the Behavioral Medicine Training Program. He is the former Secretary of the International Society of Behavioral Medicine and long time Board Member of the Society of Behavioral Medicine, and serves on the Editorial Boards of the journals Health Psychology, Psychophysiology, Diabetes Research and Clinical Practice, Psychosomatic Medicine, and the International Journal of Psychophysiology. He is a member of American Psychological Association, the American Psychosomatic Society, and the Society of Behavioral Medicine, and is also Chairman of the Financial Planning Committee and Program Advisor for the upcoming Eleventh International Congress of Behavioral Medicine, to be held in Washington, DC in 2010.
Previously, Dr Gellman was the Program Chair for the Society of Behavioral Medicine and the Program Co-chair for the International Society of Behavioral Medicine. He served on the Editorial Board of the Sage Publications scientific book series Behavioral Medicine and Health Psychology from 1997 to 2004. He also served as Program Advisor for the Tenth International Congress of Behavioral Medicine, held in Tokyo in August 2008.
Rick Turner, PhD, PGCE, MICR CSci, MTOPRA, is Drug Safety Scholar and Associate Professor of Clinical Research at the Campbell University School of Pharmacy, Research Triangle Park, NC. Dr Turner’s initial academic career was in the field of Cardiovascular Behavioral Medicine, conducting research at three US academic medical centers (the University of North Carolina at Chapel Hill, the University of Tennessee, Memphis, and the Medical College of Georgia). During this time he held professorships in Psychiatry, Pediatrics, and Preventive Medicine. He published 50 peer-reviewed papers in top-tier journals (including Annals of Behavioral Medicine and the International Journal of Behavioral Medicine), and received two international research awards for his work in Cardiovascular Behavioral Medicine. He also published the first student textbook in the field of Cardiovascular Reactivity, and four professional edited volumes in the field of Behavioral Medicine. Two of these volumes were published by Springer, and one of them (Hayman LL, Mahon MM, Turner JR, 2002, Health and Behavior in Childhood and Adolescence) received a Book of the Year Award from the American Journal of Nursing. Previously, he was the founding Editor and Editor-in-Chief of the Sage Publications scientific book series Behavioral Medicine and Health Psychology from 1997 to 2004 (as noted above, Dr Turner selected Dr Gellman to sit on the series’ Editorial Board).
Dr Turner’s current interests are in the design, implementation, and analysis of pharmaceutical clinical trials, and in the field of drug safety. He has published three textbooks and multiple invited papers in these fields, and is regularly invited to speak at international meetings. His work in clinical trials has earned him two Awards from GlaxoSmithKline, and invited Memberships of the Institute of Clinical Research, the (British) Science Council, and The Organisation for Professionals in Regulatory Affairs. He is also a member of the Society of Clinical Trials and the Drug Information Association. He is particularly interested in the application of Behavioral Medicine principles in pharmacotherapy, e.g., how to improve adherence to pharmaceutical regimens, and how to minimize medication errors to the greatest extent possible.